Dermatology NCCI edits and bundling: biopsy, excision, and destruction pairs.
Dermatology stacks more distinct procedures into one visit than almost any other specialty, which means it also stacks more NCCI bundling exposure — a biopsy, an excision, a destruction, and an E/M can all land on the same claim from the same encounter. The pillar covers the shape of this problem; this guide covers the exact pairs that generate the volume: biopsy plus excision of the same lesion, destruction plus same-day E/M, multiple destruction codes billed the same date, and excision billed alongside adjacent tissue transfer repair — plus the MUE unit caps on the lesion-count codes that trip up practices doing real multi-lesion volume.
Key takeaways
- The modifier indicator, not the pair itself, decides whether an edit is appealable. Biopsy-plus-excision of the same lesion is a 1 — fightable with the right documentation. Excision billed with adjacent tissue transfer for the same defect behaves as a 0 — CPT's own guidance rules it out regardless of documentation.
- 17110 and 17111 are single lines, not per-lesion units. Billing two units of 17110 claims 28 lesions in one session — that's not a bigger visit, it's almost always a duplicate charge.
- +17003's own descriptor caps it at 13 units — lesions 2 through 14 — because the 15th lesion moves the whole encounter to 17004. That ceiling is derivable from the code text itself, not a guess.
- Destruction-plus-E/M same day runs through modifier 25, not 59. Treating it as a 59-type unbundling problem is a common category error that leads staff to the wrong modifier and the wrong appeal argument.
Why dermatology bundles so densely
A single dermatology encounter routinely contains more than one billable procedure: a lesion gets biopsied, a different lesion gets destroyed, a third gets excised, and the visit itself may support a separately identifiable E/M. Each of those pairings has its own NCCI logic, and treating all of them as "the same kind of bundling problem" is exactly how staff end up appealing claims that were never going to reverse, or missing an appeal on one that would have. Two values decide the outcome for any pair: the NCCI modifier indicator (0, 1, or 9) for procedure-to-procedure edits, and the MUE Adjudication Indicator for per-code unit caps. Neither is a guess, and neither should be assumed from memory.
The modifier indicator refresher
- 0Never bypassable. No modifier overrides it, regardless of documentation quality. If a pair carries a 0, the second code isn't separately payable, full stop — staff time spent appealing it is wasted.
- 1Bypassable with documentation. An NCCI-associated modifier (59 or the specific X-modifier) can override the edit, but only where the record shows the second service was genuinely distinct — separate lesion, separate site, separate clinical decision.
- 9Edit deleted. The pair no longer applies; the indicator itself carries no meaning going forward.
The four pairs that drive dermatology's bundling volume
| Pair | Typical indicator | What makes the override defensible |
|---|---|---|
| Biopsy (11102–11107) + excision (11400–11646/11600–11646) of the same lesion, same session | 1 — overridable | Biopsy result (e.g., intraoperative frozen section) genuinely changed the surgical plan before excision; excision wasn't already the plan regardless of biopsy findings |
| Destruction (17000–17004, 17110–17111, 17260–17286) + E/M same day | 1, addressed with modifier 25 — not 59 | E/M is a significant, separately identifiable service beyond the work already bundled into the minor procedure's global period; this is a global-surgery-package interaction as much as an NCCI one |
| Multiple destruction codes, different lesion pathology, same date (e.g., 17000 for AK + 17110 for a benign lesion) | Generally separately payable — different code families for different lesion types, not a Column 1/Column 2 pair | Chart clearly documents which lesion(s) received which technique and which pathology category each falls under |
| Excision or destruction + adjacent tissue transfer repair (14000–14302) for the same defect | 0 — not bypassable | None available — CPT's own parenthetical instruction excludes separately reporting the excision when an ATT code covers the same primary defect |
The third row is the one most guides get backwards: multiple destruction codes on the same date are not automatically a bundling problem, because 17000–17004 (actinic keratosis), 17110–17111 (other benign lesions), and 17260–17286 (malignant) are separate code families keyed to lesion pathology, not overlapping descriptions of the same work. Billing 17000 for an AK on the forehead and 17110 for a seborrheic keratosis on the back in the same visit is two legitimately different services, not a duplicate. Where this goes wrong is when the same family is billed twice for what should have been one line — two units of 17110 instead of one line reflecting the actual lesion count — which is a unit-count (MUE) problem, not a Column 1/Column 2 bundling problem. Keeping that distinction straight is what the MUE section below is for.
⚠️ Industry coding references consistently describe the biopsy/excision and ATT pairs the way this table presents them, but this build could not open CMS's primary NCCI PTP edit files or the NCCI Policy Manual PDF directly to re-confirm the current-quarter indicator value for each specific code pair (CMS's site returned an access error to every automated fetch attempt made while researching this page). Look up the live value for the exact codes you're billing in the CMS NCCI PTP Edits Lookup Tool before building any of this into a scrubber rule, since values are pair-specific and revised quarterly.
Destruction plus E/M: why it's a 25 problem, not a 59 problem
This pair gets miscategorized constantly because it looks like the other bundling problems on this page. It isn't quite the same mechanism. Destruction codes carry a 0- or 10-day global period, and the global surgery package already includes the E/M work directly tied to the decision to perform the minor procedure. NCCI enforces that bundling through E/M-versus-minor-procedure edit pairs, and the override is modifier 25 — appended to the E/M line, not modifier 59 appended to the procedure. Reaching for 59 on this pair is a common and telling error, because it signals staff are pattern-matching to the biopsy/excision or destruction/ATT bundling logic instead of the global-period logic that actually governs this specific pair.
The E/M has to be significant and separately identifiable from the work of deciding to destroy the lesion. Evaluating and documenting a second, unrelated skin concern at the same visit as a destruction procedure supports 25; an E/M billed for a visit that consisted entirely of examining the one lesion that got destroyed does not, regardless of how thorough the note reads.
MUE unit caps on the lesion-count codes
MUE limits matter most in dermatology precisely because so many of its codes are lesion-count-driven. Reading the code descriptor correctly often tells you the cap before you ever need to look one up.
| Code | What the descriptor already caps | Unit-billing pattern |
|---|---|---|
17000 | First AK lesion only | 1 unit per day, by definition — a second unit would mean a second "first lesion," which isn't possible |
+17003 | Lesions 2 through 14 (13 lesions) | Maximum 13 units; the 15th lesion moves the whole encounter to 17004, not a 14th unit of +17003 |
17004 | 15 or more AK lesions, as one code | 1 unit regardless of how far past 15 the count goes — it replaces the 17000/+17003 combination entirely |
17110 | Up to 14 benign lesions (excluding AK), as one code | 1 unit per day; billing 2+ units implies 28+ lesions in one session, which is almost never real |
17111 | 15 or more benign lesions, as one code | 1 unit per day regardless of count above 15 |
11400–11446/11600–11646 | One code represents one excised lesion at one size/location band | Each additional lesion is typically a different code (different size or location) reported on a separate line with modifier 59/XS, not additional units of the same code |
⚠️ The lesion-count logic above is derived directly from each code's own CPT descriptor and is confident regardless of the current MUE table. The specific numeric MUE value and MAI (MUE Adjudication Indicator) CMS has assigned to each of these codes for the current quarter could not be independently re-confirmed against CMS's published MUE files during this build for the same access-error reason noted above — check the current MUE and MAI for any code before assuming a high-count claim will pass edits or that a denial is appealable.
Before treating an MUE denial as a real multi-lesion claim that needs an appeal, check the order queue first. A same-code, same-date line that looks unusually high is far more often two orders for what should have been one charge-capture event — a nurse and a physician both logging the same destruction, or an EHR charge trigger firing twice — than it is a genuinely large lesion count. Confirm the lesion count against the note before spending appeal time on a denial that's actually a workflow duplicate.
Do and don't
- Check the modifier indicator for the specific pair before appending 59, an X-modifier, or 25.
- Read the code descriptor before assuming an MUE denial reflects a coding error rather than a duplicate charge.
- Document the biopsy's clinical decision-making impact explicitly when billing it alongside a same-lesion excision.
- Bill different destruction code families for different lesion pathologies treated the same visit — that's not bundling.
- Don't append modifier 59 to override the destruction/E/M pairing — that's a 25 decision, not a 59 decision.
- Don't bill an excision code alongside adjacent tissue transfer repair for the same defect; CPT's own guidance excludes it.
- Don't bill multiple units of 17110 or 17111 to reflect a higher lesion count — each code already represents a lesion-count range as one line.
- Don't write a bundling appeal before confirming the indicator is a 1, not a 0.
Bundling denials eating into your dermatology revenue?
We'll audit a sample of your recent claims for biopsy/excision, destruction, and repair bundling patterns, and show which denials are actually appealable versus which ones need a workflow fix instead.
Frequently asked questions
What NCCI modifier indicator applies when a biopsy and an excision are billed for the same lesion the same day?
Industry coding references consistently describe this pair as carrying a modifier indicator of 1, meaning an NCCI-associated modifier can override the edit, but only when the documentation shows the biopsy drove a genuinely separate clinical decision — most commonly an intraoperative frozen section that changed the surgical plan before the excision was performed. Routine same-session biopsy plus excision of the same lesion, where the excision was already planned regardless of the biopsy result, doesn't meet that bar and the biopsy denies as bundled into the excision. Confirm the live indicator for the specific code pair you're billing in the CMS NCCI PTP Edits Lookup Tool before building it into a scrubber rule, since values are pair-specific and revised quarterly.
Can destruction or excision be billed together with adjacent tissue transfer repair for the same lesion?
No — CPT's own parenthetical instruction under the adjacent tissue transfer codes (14000-14302) states not to separately report an excision code for the lesion the flap or graft is repairing, because the ATT code's "primary defect" already includes removing the lesion. This is treated as a hard, non-bypassable bundle in practice, equivalent to a modifier indicator of 0 — no amount of documentation makes the excision separately payable when an ATT code is billed for the same defect the same session. Bill the ATT code alone at the size of the primary plus secondary defect; billing the excision code alongside it is one of dermatology's more consequential bundling errors because it inflates the claim rather than just risking a partial denial.
How do we tell a legitimate multi-lesion destruction claim from an MUE trip caused by duplicate orders?
Start with what the code itself already represents: 17110 and 17111 are each a single line covering a lesion-count range (up to 14, and 15 or more), not a per-lesion unit — so two units of 17110 on one date claims 28 lesions in one session, which is implausible and is far more often a duplicate charge entry than a real count. The destruction add-on +17003 is capped at 13 units by its own descriptor (lesions 2 through 14), so anything approaching that ceiling should be cross-checked against the visit note's lesion count before submission, not after an MUE denial. If a same-code, same-date line looks unusually high, check the order history first — two orders for what should have been one charge-capture event is the single most common cause, not an unusually large lesion count.
Verify before billing. CPT is a registered trademark of the American Medical Association; codes here are paraphrased, not reproduced from the CPT Professional edition. CPT, HCPCS and ICD-10 codes, coverage policy, and bundling edits change, including annual code-set updates. This page reflects standard industry practice and is provided for general education — it is not a substitute for your own compliance review, your current payer contracts, or the current-year code sets. Confirm requirements against your specific payer mix before submitting claims.